Jw Pharmac (001060) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.132x

Based on the latest financial reports, Jw Pharmac (001060) has a cash flow conversion efficiency ratio of 0.132x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩46.92 Billion ≈ $31.79 Million USD) by net assets (₩354.10 Billion ≈ $239.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jw Pharmac - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Jw Pharmac's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 001060 total debt and obligations for a breakdown of total debt and financial obligations.

Jw Pharmac Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jw Pharmac ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Light S.A SA:LIGT3	-0.019x
Hangzhou Prevail Optoelectronic Equipment Co Ltd SHE:300710	0.022x
Canopy Growth Corp NASDAQ:CGC	-0.023x
Orthofix Medical Inc NASDAQ:OFIX	0.063x
Westrock Coffee Company NASDAQ:WEST	0.135x
Wijaya Karya Beton PT JK:WIKA	-0.044x
Menivim The New REIT Ltd TA:MNRT	0.033x
Chengdu Tianjian Technology Co Ltd SHE:002977	-0.045x

Annual Cash Flow Conversion Efficiency for Jw Pharmac (2001–2024)

The table below shows the annual cash flow conversion efficiency of Jw Pharmac from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see Jw Pharmac stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩329.49 Billion ≈ $223.29 Million	₩79.39 Billion ≈ $53.80 Million	0.241x	-26.62%
2023-12-31	₩265.44 Billion ≈ $179.89 Million	₩87.16 Billion ≈ $59.07 Million	0.328x	+30.59%
2022-12-31	₩225.76 Billion ≈ $152.99 Million	₩56.76 Billion ≈ $38.47 Million	0.251x	+161.57%
2021-12-31	₩188.54 Billion ≈ $127.77 Million	₩18.12 Billion ≈ $12.28 Million	0.096x	-68.37%
2020-12-31	₩207.47 Billion ≈ $140.60 Million	₩63.05 Billion ≈ $42.73 Million	0.304x	+25.93%
2019-12-31	₩230.09 Billion ≈ $155.93 Million	₩55.53 Billion ≈ $37.63 Million	0.241x	+20.47%
2018-12-31	₩260.11 Billion ≈ $176.27 Million	₩52.11 Billion ≈ $35.31 Million	0.200x	+62.17%
2017-12-31	₩270.78 Billion ≈ $183.50 Million	₩33.45 Billion ≈ $22.67 Million	0.124x	+406.54%
2016-12-31	₩276.31 Billion ≈ $187.25 Million	₩6.74 Billion ≈ $4.57 Million	0.024x	+231.67%
2015-12-31	₩225.41 Billion ≈ $152.75 Million	₩-4.17 Billion ≈ $-2.83 Million	-0.019x	-156.95%
2014-12-31	₩223.83 Billion ≈ $151.68 Million	₩7.28 Billion ≈ $4.93 Million	0.033x	-65.14%
2013-12-31	₩200.74 Billion ≈ $136.04 Million	₩18.72 Billion ≈ $12.69 Million	0.093x	-76.23%
2012-12-31	₩163.66 Billion ≈ $110.91 Million	₩64.21 Billion ≈ $43.52 Million	0.392x	+1233.92%
2006-12-31	₩172.48 Billion ≈ $116.89 Million	₩5.07 Billion ≈ $3.44 Million	0.029x	-95.00%
2005-12-31	₩119.44 Billion ≈ $80.95 Million	₩70.25 Billion ≈ $47.61 Million	0.588x	+367.61%
2004-12-31	₩119.39 Billion ≈ $80.91 Million	₩15.02 Billion ≈ $10.18 Million	0.126x	-16.92%
2003-12-31	₩112.60 Billion ≈ $76.31 Million	₩17.05 Billion ≈ $11.55 Million	0.151x	-46.93%
2002-12-31	₩100.72 Billion ≈ $68.26 Million	₩28.74 Billion ≈ $19.47 Million	0.285x	-43.68%
2001-12-31	₩88.92 Billion ≈ $60.26 Million	₩45.04 Billion ≈ $30.52 Million	0.507x	--

About Jw Pharmac

KO:001060 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$476.78 Million

₩703.54 Billion KRW

Market Cap Rank

#12766 Global

#412 in Korea

Share Price

₩31200.00

Change (1 day)

-2.80%

52-Week Range

₩20950.00 - ₩39050.00

All Time High

₩75306.05